Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of JTT-130 in obese patients with type 2 diabetes mellitus
2009-011965-10Phase 2Completed
- Sponsor
- Akros Pharma Inc.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and obesity comparing JTT-130 twice daily with Placebo twice daily (2 arms). Primary endpoint: Change in HbA1c from baseline to end of treatment. Started Jun 2009; status: completed.
02
Drugs
granotapide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on 2009-011965-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011965-10.